4//SEC Filing
Jallal Bahija 4
Accession 0001104659-24-007732
CIK 0001868279other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:15 PM ET
Size
5.5 KB
Accession
0001104659-24-007732
Insider Transaction Report
Form 4
Jallal Bahija
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-25+17,884→ 17,884 totalExercise: $18.00Exp: 2034-01-24→ Common Stock (17,884 underlying)
Footnotes (1)
- [F1]These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
ArriVent Biopharma, Inc.
CIK 0001868279
Entity typeother
Related Parties
1- filerCIK 0001730038
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:15 PM ET
- Size
- 5.5 KB